Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$32.20 +0.33 (+1.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Arcutis Biotherapeutics (ARQT) Net Debt Issuances and Repayments (2021)

Updated

Analysis

Arcutis Biotherapeutics (ARQT) Net Debt Issuances and Repayments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,144.40 Bn 1,112.99 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.88 Bn 554.74 Bn 17.30 Bn -4.36 Bn
3 AbbVie 500.40 Bn 473.51 Bn 12.70 Bn -2.00 Bn
4 Merck 356.05 Bn 310.43 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 301.50 Bn 265.49 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 264.72 Bn 238.40 Bn 12.86 Bn -2.46 Bn
7 Amgen 238.14 Bn 193.54 Bn 7.24 Bn -
8 Gilead Sciences 195.19 Bn 169.39 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn 64.00 Mn
10 Arcutis Biotherapeutics 4.12 Bn 3.40 Bn 118.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 73.99 Mn
API Access

Arcutis Biotherapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=ARQT&period=max&api_key=YOUR_API_KEY